New ransomware targeting Apple macOS users via pirated apps - Chennai News
by Maria Thomas
Updated Jul 03, 2020
This is the second Mac malware discovered by K7 Computing, a global cybersecurity firm, after the fileless Trojan identified last December.
Ransomware threats encrypt the victim's files and demand a ransom for decryption.
'EvilQuest' goes further and also installs a keylogger to record the user's keystrokes, a reverse shell that allows the attacker to run custom commands, and will also steal files commonly used by crypto-currency wallets, the company said in a statement on Friday.
EvilQuest demands $50 in Bitcoin to decrypt the files but even if the attackers decrypt the files on receipt of ransom, they retain the ability to steal the victim's credentials and files through the other malware installed along with the ransomware.
"EvilQuest demonstrates that cybercriminals rapidly evolve attacks on every platform. By bundling ransomware with other malware they create threats that remain malicious even after the ransom is paid, confirming the futility of paying ransom to cyber attackers," said J Kesavardhanan, Founder and CEO of K7 Computing.
Apple was yet to comment on the report.
K7 Threat Labs was formed to be at the forefront of malware analysis and repeatedly discovering new attacks.
"The ongoing Covid-19 scenario has given rise to increased levels of cyber threats and hacks and new strains of malware are on the upswing," said the researchers.
Related Articles
- Optical Illusion Brain Test: If you have Sharp Eyes Find the Number 442 in 20 Secs
- London-based firm Nothing to release its Phone (2)
- Covid will continue to cause mini-waves, not become seasonal yet: Scientists
- Hackers offering crypto accounts for as low as $30 on darknet
- Reddit's new feature to allow users to share its content on other platforms
- Surgical masks can help kids fight respiratory infections: Study
- LinkedIn's new AI feature to write messages to hiring team
- Microsoft introduces Xbox Game Pass' new Friend Referral programme
- Disbursed over Rs 31 cr in claims to delivery partners in FY22-23: Swiggy
- India emerging as favourable destination for clinical trials: Report